Mean (SD) baseline characteristics of patients entering the study.
| Supplement (n=42) | Placebo (n=43) | |
|---|---|---|
| FEV1=forced expiratory volume in 1 second; BMI=body mass index; ISWT, ESWT=incremental and endurance shuttle walk tests; HGS=hand grip strength; QS=quadriceps strength. | ||
| Dietary macronutrient values are mean daily intakes. There was no statistically significant difference between treatment groups at baseline. | ||
| *Median (IQR) values. | ||
| F:M | 16:26 | 16:27 |
| Age | 66 (9.0) | 68 (8.0) |
| FEV1 (l) | 0.91 (0.42) | 0.84 (0.31) |
| FEV1 (% predicted) | 34.7 (13.6) | 34.4 (14.3) |
| Weight (kg) | 67.4 (14.2) | 65.4 (11.9) |
| BMI (kg/m2) | 23.9 (3.5) | 23.5 (3.8) |
| Lean mass (kg) | 43.3 (9.4) | 42.4 (9.0) |
| Fat mass (kg) | 20.8 (8.4) | 19.4 (8.9) |
| ISWT (m) | 210 (113) | 220 (123) |
| ESWT (s)* | 163 (132) | 219 (159) |
| HGS (kg force) | 27.6 (7.2) | 27.1 (8.6) |
| QS (N) | 305 (105) | 305 (113) |
| Total calorie intake (kcal) | 1832 (536) | 1719 (494) |
| Carbohydrate intake (g) | 210 (60) | 208 (71) |
| Protein intake (g) | 73 (20) | 68 (21) |
| Fat intake (g) | 75 (30) | 70 (23) |